FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 251 filers reported holding FATE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $374,000 | -29.2% | 9,640 | +6.7% | 0.05% | -38.0% |
| Q4 2021 | $528,000 | -91.1% | 9,038 | -91.0% | 0.08% | -81.1% |
| Q3 2021 | $5,928,000 | -34.1% | 100,000 | -3.5% | 0.42% | -42.6% |
| Q2 2021 | $8,993,000 | -3.0% | 103,600 | -7.9% | 0.73% | +133.0% |
| Q1 2021 | $9,275,000 | +32.0% | 112,500 | +45.5% | 0.31% | +0.6% |
| Q4 2020 | $7,029,000 | +75.5% | 77,300 | -22.9% | 0.31% | +6.9% |
| Q3 2020 | $4,006,000 | +16.5% | 100,200 | 0.0% | 0.29% | +5.8% |
| Q2 2020 | $3,438,000 | +54.4% | 100,200 | 0.0% | 0.27% | +63.1% |
| Q1 2020 | $2,226,000 | – | 100,200 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $7,163,616 | 2.64% |
| Redmile Group, LLC | 13,124,427 | $27,823,785 | 1.32% |
| Monaco Asset Management SAM | 1,847,944 | $3,917,641 | 1.16% |
| Casdin Capital, LLC | 2,050,000 | $4,346,000 | 0.48% |
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $1,484,000 | 0.21% |
| GCM Grosvenor Holdings, LLC | 495,916 | $1,051,342 | 0.21% |
| Nebula Research & Development LLC | 163,617 | $346,868 | 0.18% |
| Bellevue Group AG | 4,851,579 | $10,285,347 | 0.17% |
| Bruce & Co., Inc. | 200,000 | $424,000 | 0.14% |
| XTX Topco Ltd | 192,920 | $408,990 | 0.07% |